Delivery Order SPE2DB24D2011-SPE2DB25FBREH
- Not listed
- This is a $2,121.26 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract has a period of performance through May 20, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This is a $2,828.29 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product, with a performance period ending on November 3, 2023. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,861.78 firm fixed-price delivery order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a pharmaceutical product. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a $2,380.72 firm-fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract is for the pharmaceutical product BRIVIACT 25 MG TABLET 60S, with a period of performance through July 11, 2025. AmerisourceBergen is a major pharmaceutical distributor that holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, to provide a wide range of pharmaceutical...
- This is a $3,139.47 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the pharmaceutical product BRIVIACT 25 MG TABLET 60S. The contract has an ultimate completion date of May 28, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, enabling it to supply a wide range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,687.28, is for the delivery of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product. The order has an ultimate completion date of July 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,815.74 firm fixed-price delivery order is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a specialty medication. The contract has an ultimate completion date of November 15, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,650.26 Firm Fixed Price Delivery Order is for the supply of BRIVIACT 100 MG TABLET 60S, a pharmaceutical product, with a completion date of July 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a $3,818.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BRIVIACT 50 MG TABLET 60S. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML, a medication used in the treatment of neurological conditions. The contract has a ceiling value of $8,378.01 and a performance period ending on June 6, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBREHDelivery Order
This is a $2,108.49 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency, for the supply of BRIVIACT 10 MG/ML ORAL SOLN 300ML. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including medications across multiple therapeutic domains such as diabetes, neurology, and pain management.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 6/30/25 |